Beyond SELECT's findings in people without diabetes, semaglutide has demonstrated cardiovascular benefits across diverse patient populations, including those with type 2 diabetes and varying degrees of heart failure
Dulaglutide once weekly (QW) [6,7,8], subcutaneous (s.c.) semaglutide QW [9, 10], and oral semaglutide once daily (QD) [11] are among the GLP-1 RAs approved by the European Medicines Agency (EMA), but at the time of the study, oral semaglutide was not available in France
Nooms product will be significantly cheaper (starting at $149/month) than branded options like Wegovy or Zepbound ($349/month) by using a microdosing approach
You press the pen against your skin and it auto-injects
However, be cautious of masking one drugs side effects with anotherits a slippery slope